Adverse events must be carefully monitored and reported in a timely manner. Our support will ensure safety, as well as appropriate care and medical support for patients experiencing undesirable signs and symptoms during treatment.
Reporting of adverse events to regulatory authorities is mandatory. It requires monitoring and documenting adverse event reports according to global and national requirements. This is applicable to both clinical trials and marketed medicinal products.
Arex Advisor experts will:
– Manage adverse events in a timely manner in accordance with the applicable legislation
– Detect patient safety issues
– Mitigate relevant safety risks for clinical trials and postmarketing use of the medicinal product
Scientific literature screening
Effective PV systems for the Nordics
Local PV function, including medical information
PV training services
Lovisa Rosenquist
Staffan Thunell
Founding partner
BSc Economics and BA
Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from positions as Founder, Chairman, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.
